These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21964939)

  • 1. Influences of ORF1 on the virulence and immunogenicity of Actinobacillus pleuropneumoniae.
    Yuan F; Liu J; Guo Y; Tan C; Fu S; Zhao J; Chen H; Bei W
    Curr Microbiol; 2011 Dec; 63(6):574-80. PubMed ID: 21964939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.
    Fu S; Ou J; Zhang M; Xu J; Liu H; Liu J; Yuan F; Chen H; Bei W
    Clin Vaccine Immunol; 2013 Feb; 20(2):134-9. PubMed ID: 23220998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
    Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
    Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and immunogencity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1.
    Lin L; Bei W; Sha Y; Liu J; Guo Y; Liu W; Tu S; He Q; Chen H
    FEMS Microbiol Lett; 2007 Sep; 274(1):55-62. PubMed ID: 17608699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae.
    Schaller A; Kuhn R; Kuhnert P; Nicolet J; Anderson TJ; Maclnnes JI; Segers RPAM; Frey J
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2105-2116. PubMed ID: 10463177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
    Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo induced RTX toxin ApxIVA is essential for the full virulence of Actinobacillus pleuropneumoniae.
    Liu J; Chen X; Tan C; Guo Y; Chen Y; Fu S; Bei W; Chen H
    Vet Microbiol; 2009 Jun; 137(3-4):282-9. PubMed ID: 19251385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].
    Liu J; Chen Y; Hu L; Bei W; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
    Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
    Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].
    Xu FZ; Shi AH; Chen XL; Yang B; Wang JL
    Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):923-7. PubMed ID: 18062275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae.
    Nielsen R; van den Bosch JF; Plambeck T; Sørensen V; Nielsen JP
    Vet Microbiol; 2000 Jan; 71(1-2):81-7. PubMed ID: 10665536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs following vaccination or experimental challenge with respiratory pathogens and natural A. pleuropneumoniae serovar 1 challenge.
    Eamens GJ; Gonsalves JR; Whittington AM; Turner B
    Aust Vet J; 2012 Dec; 90(12):490-8. PubMed ID: 23186091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.
    Tonpitak W; Baltes N; Hennig-Pauka I; Gerlach GF
    Infect Immun; 2002 Dec; 70(12):7120-5. PubMed ID: 12438394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence.
    Boekema BK; Kamp EM; Smits MA; Smith HE; Stockhofe-Zurwieden N
    Vet Microbiol; 2004 May; 100(1-2):17-23. PubMed ID: 15135509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the znuA virulence factor attenuates Actinobacillus pleuropneumoniae and confers protection against homologous or heterologous strain challenge.
    Yuan F; Liao Y; You W; Liu Z; Tan Y; Zheng C; BinWang ; Zhou D; Tian Y; Bei W
    Vet Microbiol; 2014 Dec; 174(3-4):531-539. PubMed ID: 25465668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia.
    Sadilkova L; Nepereny J; Vrzal V; Sebo P; Osicka R
    Vet Res; 2012 Jan; 43(1):2. PubMed ID: 22240397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.
    Prideaux CT; Lenghaus C; Krywult J; Hodgson AL
    Infect Immun; 1999 Apr; 67(4):1962-6. PubMed ID: 10085043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs.
    Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R
    Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.